Publications (86) Estíbaliz Alegre Martínez publications

filter_list

2025

  1. Clinical utility of personalized reference intervals for CEA in the early detection of oncologic disease

    Clinical Chemistry and Laboratory Medicine, Vol. 63, Núm. 2, pp. 376-386

  2. Routine data analysis for moderate hemolysis interference correction in neuron specific enolase quantification

    Biochemia Medica, Vol. 35, Núm. 2

  3. Screening with Metoclopramide Test to Reduce Unnecessary Pituitary Magnetic Resonance Studies in Moderate Hyperprolactinemia

    The journal of applied laboratory medicine, Vol. 10, Núm. 1, pp. 48-58

  4. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut, Vol. 74, Núm. 2, pp. 270-283

2024

  1. Extracellular vesicles in cancer: challenges and opportunities for clinical laboratories

    Critical Reviews in Clinical Laboratory Sciences, Vol. 61, Núm. 6, pp. 435-457

  2. Tracking dynamic evolution of low- and intermediate-risk differentiated thyroid cancer: Identification of individuals at risk of recurrence

    Clinical Endocrinology, Vol. 101, Núm. 3, pp. 286-294

2023

  1. Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma

    Clinica Chimica Acta, Vol. 548

  2. MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated

    Frontiers in Cell and Developmental Biology, Vol. 10

  3. PSA reactivity in extracellular microvesicles to commercial immunoassays

    Clinica Chimica Acta, Vol. 543

2022

  1. Impact of ultra-low temperature long-term storage on the preanalytical variability of twenty-one common biochemical analytes

    Clinical Chemistry and Laboratory Medicine, Vol. 60, Núm. 7, pp. 1003-1010

  2. Modification of baseline status to improve breath tests performance

    Scientific Reports, Vol. 12, Núm. 1

  3. Questionable High Free T4 Concentrations: When Confirming against an Alternative Method Is Not Enough

    Clinical chemistry, Vol. 68, Núm. 9, pp. 1128-1132

2021

  1. Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients

    Cytokine, Vol. 141

  2. Exosomes in lung cancer: Actors and heralds of tumor development

    Cancers, Vol. 13, Núm. 17

  3. mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 207-219

2020

  1. Estudio del test de tolerancia a lactosa como alternativa a test de hidrógeno espirado en el estudio de la malabsorción de lactosa

    Advances in Laboratory Medicine, Vol. 1, Núm. 4

  2. Lactose tolerance test as an alternative to hydrogen breath test in the study of lactose malabsorption

    Advances in Laboratory Medicine, Vol. 1, Núm. 4

  3. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients

    Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 8, pp. 1341-1348

  4. Realización de pruebas innecesarias en los ensayos clínicos: HCG como ejemplo

    Advances in Laboratory Medicine

  5. Unnecessary test ordering in clinical trials: Human chorionic gonadotropin as an example

    Advances in Laboratory Medicine